# Glaxo Operations UK Limited – FDA Inspection, Sep 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/93a229ee-cd04-416d-8be7-71aad893fb17
Source feed: FDA_Inspections

> FDA inspection 1102175 of Glaxo Operations UK Limited, September 06, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102175
- Company Name: Glaxo Operations UK Limited
- Inspection Date: 2019-09-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1267917 - 2024-12-06
- FDA Inspection 1099616 - 2019-01-25
- FDA Inspection 935343 - 2015-07-10
- FDA Inspection 898406 - 2014-09-12
- FDA Inspection 827578 - 2013-04-25

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)

Company: https://www.keypedia.com/companies/glaxo-operations-uk-limited/203ed5e0-7ae4-490f-b37a-9293e17eae84

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
